PROMIS NEUROSCIENCES

PMN
Delayed Quote. Delayed  - 01/22 03:59:52 pm
0.11CAD --.--%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 0,00-
EBITDA --
Operating profit (EBIT)1 -7,40-6,80
Operating Margin -616 355%-
Pre-Tax Profit (EBT)1 -7,40-6,80
Net income1 -7,40-6,80
Net margin -616 355%-
EPS2 -0,02-0,02
Dividend per Share --
Last update 03/18/2020-
1 CAD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt --
Net Cash position --
Leverage (Debt / EBITDA) --
Free Cash Flow --
ROE (Net Profit / Equities) --
Shareholders' equity1 --
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share --
Cash Flow per Share --
Capex --
Capex / Sales --
Last update 03/18/202008/24/2020
1 CAD in Million
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 32 M CAD -
Valuation 2020e 2021e
P/E ratio (Price / EPS) -5,76x -2,88x
Capitalization / Revenue - -
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) - -
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) - -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   - -
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend